SCM
ZVSA

Saba Capital Management’s ZyVersa Therapeutics ZVSA Stock Holding History

Saba Capital Management’s Portfolio ZVSA Stock Details ZVSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-1,705
Closed -$5.97M – 954
2022
Q3 		$5.97M Buy
1,705
+36
+2% +$126K 0.08% 484
2022
Q2 		$5.8M Buy
1,669
+314
+23% +$1.09M 0.08% 481
2022
Q1 		$4.7M Buy
+1,355
New +$4.69M 0.08% 447

Other funds holding ZVSA

Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return
CL
CSS LLC Chicago, Illinois $1.8B AUM 59.56% 1-Year Est. Return